Market Access Opportunity Stratis specializes in market access solutions for pharmaceutical, biotechnology, and academic organizations, presenting a clear opening to offer end-to-end services from pricing and payer strategy to patient support and field execution for launch-ready brands.

Post-Launch Optimization With capabilities spanning pre- and post-launch activities, there is a sales angle to position Stratis as a partner for sustaining performance, optimizing patient services, and improving pull-through in competitive markets.

Integrated Capabilities Integrated offerings in HEOR, real-world evidence, analytics, and launch planning create cross-sell opportunities with clients seeking cohesive strategies rather than point solutions.

Strong Growth Footprint Mid-sized firm with 51-200 employees and revenue in the hundred-million range signals agility and depth, making it attractive to mid-market life sciences companies seeking strategic partnerships without the scale of the largest consultancies.

Strategic Partnerships As part of Nexus Health within Lockwood Group, Stratis can leverage corporate connections to expand into enterprise accounts, offering joint solutions around access, patient support, and reimbursement to accelerate market uptake.